<?xml version="1.0" encoding="UTF-8"?>
<p>Research approaches to diminish opioid liabilities take advantage of the current concept of functional selectivity, with biased ligands (agonists and antagonists) as innovative opportunities for opioid pain therapy and use management, subjects reviewed in [
 <xref rid="B12-molecules-25-05658" ref-type="bibr">12</xref>,
 <xref rid="B15-molecules-25-05658" ref-type="bibr">15</xref>,
 <xref rid="B16-molecules-25-05658" ref-type="bibr">16</xref>,
 <xref rid="B17-molecules-25-05658" ref-type="bibr">17</xref>] and explored in a research article [
 <xref rid="B18-molecules-25-05658" ref-type="bibr">18</xref>].
</p>
